EP1504026A4 - Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation - Google Patents
Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisationInfo
- Publication number
- EP1504026A4 EP1504026A4 EP02794126A EP02794126A EP1504026A4 EP 1504026 A4 EP1504026 A4 EP 1504026A4 EP 02794126 A EP02794126 A EP 02794126A EP 02794126 A EP02794126 A EP 02794126A EP 1504026 A4 EP1504026 A4 EP 1504026A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- encodings
- methods
- same
- nucleic acids
- therapeutic polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- AIDS & HIV (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (39)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33660001P | 2001-12-05 | 2001-12-05 | |
US336600P | 2001-12-05 | ||
US33828501P | 2001-12-07 | 2001-12-07 | |
US338285P | 2001-12-07 | ||
US34134601P | 2001-12-12 | 2001-12-12 | |
US341346P | 2001-12-12 | ||
US34154001P | 2001-12-17 | 2001-12-17 | |
US34147701P | 2001-12-17 | 2001-12-17 | |
US341477P | 2001-12-17 | ||
US341540P | 2001-12-17 | ||
US34259201P | 2001-12-20 | 2001-12-20 | |
US342592P | 2001-12-20 | ||
US34429701P | 2001-12-27 | 2001-12-27 | |
US344297P | 2001-12-27 | ||
US34490301P | 2001-12-31 | 2001-12-31 | |
US344903P | 2001-12-31 | ||
US37328802P | 2002-04-17 | 2002-04-17 | |
US373288P | 2002-04-17 | ||
US38098102P | 2002-05-15 | 2002-05-15 | |
US380981P | 2002-05-15 | ||
US38149502P | 2002-05-17 | 2002-05-17 | |
US381495P | 2002-05-17 | ||
US38374402P | 2002-05-28 | 2002-05-28 | |
US38353402P | 2002-05-28 | 2002-05-28 | |
US383744P | 2002-05-28 | ||
US383534P | 2002-05-28 | ||
US38382902P | 2002-05-29 | 2002-05-29 | |
US38402402P | 2002-05-29 | 2002-05-29 | |
US383829P | 2002-05-29 | ||
US384024P | 2002-05-29 | ||
US40178802P | 2002-08-07 | 2002-08-07 | |
US401788P | 2002-08-07 | ||
US40635302P | 2002-08-26 | 2002-08-26 | |
US406353P | 2002-08-26 | ||
US42275602P | 2002-10-31 | 2002-10-31 | |
US422756P | 2002-10-31 | ||
US309290 | 2002-12-02 | ||
US10/309,290 US20040023241A1 (en) | 2001-12-05 | 2002-12-02 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
PCT/US2002/038594 WO2003050245A2 (fr) | 2001-12-05 | 2002-12-03 | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1504026A2 EP1504026A2 (fr) | 2005-02-09 |
EP1504026A4 true EP1504026A4 (fr) | 2005-12-21 |
Family
ID=32303940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02794126A Withdrawn EP1504026A4 (fr) | 2001-12-05 | 2002-12-03 | Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1504026A4 (fr) |
JP (1) | JP2006507793A (fr) |
AU (1) | AU2002359579A1 (fr) |
CA (1) | CA2467721A1 (fr) |
WO (1) | WO2003050245A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252267B2 (en) | 2005-03-30 | 2012-08-28 | Sagres Discovery, Inc. | DKKL-1 splice product modulators for cancer diagnosis and therapy |
JPWO2008093827A1 (ja) * | 2007-02-01 | 2010-05-20 | 財団法人大阪産業振興機構 | 中枢神経障害治療剤及び中枢神経障害の治療方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007740A2 (fr) * | 1997-08-06 | 1999-02-18 | Zymogenetics, Inc. | Homologues de lipocaline |
WO2001059155A2 (fr) * | 2000-02-11 | 2001-08-16 | Pharma Pacific Pty. Ltd. | Genes induits par l'interferon-alpha |
-
2002
- 2002-12-03 CA CA002467721A patent/CA2467721A1/fr not_active Abandoned
- 2002-12-03 AU AU2002359579A patent/AU2002359579A1/en not_active Abandoned
- 2002-12-03 EP EP02794126A patent/EP1504026A4/fr not_active Withdrawn
- 2002-12-03 WO PCT/US2002/038594 patent/WO2003050245A2/fr not_active Application Discontinuation
- 2002-12-03 JP JP2003551267A patent/JP2006507793A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999007740A2 (fr) * | 1997-08-06 | 1999-02-18 | Zymogenetics, Inc. | Homologues de lipocaline |
WO2001059155A2 (fr) * | 2000-02-11 | 2001-08-16 | Pharma Pacific Pty. Ltd. | Genes induits par l'interferon-alpha |
Non-Patent Citations (1)
Title |
---|
DATABASE EMBL [online] 14 January 1992 (1992-01-14), "Homo sapiens mRNA for von Ebner's gland protein", XP002335191, retrieved from EBI accession no. EM_PRO:HSVEGP Database accession no. HSVEGP * |
Also Published As
Publication number | Publication date |
---|---|
JP2006507793A (ja) | 2006-03-09 |
WO2003050245A2 (fr) | 2003-06-19 |
AU2002359579A1 (en) | 2003-06-23 |
WO2003050245A8 (fr) | 2004-05-13 |
CA2467721A1 (fr) | 2003-06-19 |
WO2003050245A3 (fr) | 2004-12-16 |
EP1504026A2 (fr) | 2005-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003023008A8 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes | |
EP1576169A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees | |
EP1487864A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees | |
AU2002356534A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1446419A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation | |
EP1432726A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces derniers et methodes d'utilisation correspondantes | |
EP1401858A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
AU2003217956A8 (en) | Therapeutic polypeptides, nucleic acids encoding same and methods of use | |
EP1532238A4 (fr) | Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant | |
EP1539985A4 (fr) | Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides, et procedes d'utilisation | |
EP1443913A4 (fr) | Polypeptides therapeutiques, acides nucleiques encodant ces polypeptides et leurs procedes d'utilisation | |
EP1399537A4 (fr) | Polypeptides therapeutiques, acides nucleiques les codant, et procedes d'utilisation | |
EP1549671A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation associees | |
AU2002309646A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same | |
EP1504026A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation | |
AU2002365216A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2003304034A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003060149A9 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation | |
AU2002365189A8 (en) | P85-alpha nucleic acids, polypeptides and related methods | |
AU2003270424A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2002360485A8 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
AU2002322405A1 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
EP1539807A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation | |
EP1513864A4 (fr) | Polypeptides therapeutiques, acides nucleiques codant ces derniers et leurs procedes d'utilisation | |
AU2002303232A1 (en) | Novel human proteins, polynucleotides encoding them and methods of using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040701 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO |
|
R17D | Deferred search report published (corrected) |
Effective date: 20041216 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 07K 14/81 B Ipc: 7C 07K 14/47 B Ipc: 7C 07K 1/00 B Ipc: 7C 07K 14/435 A |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CURAGEN CORPORATION |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20051104 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060124 |